Chemours Company (the) · NYSE:CC

Chemours Company (the) — Q2 2024 Earnings Presentation

12 slides from Chemours Company (the)'s earnings presentation, Aug 2, 2024

  1. Slide 1: Second Quarter 2024 Earnings Presentation

    Second Quarter 2024 Earnings Presentation August 1, 2024

  2. Slide 2: Safe Harbor Statement and Other Matters

    Safe Harbor Statement and Other Matters We prepare our financial statements in accordance with Generally Accepted Accounting Principles (GAAP). Within this press release, we may make reference to Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, Total Debt Principal, Net and Net Leverage Ratio whi

  3. Slide 3: Second Quarter 2024 Highlights

    Second Quarter 2024 Highlights Generated $1.5B in Net Sales and $206M in Adjusted EBITDA Delivered 16% sequential volume growth in TT segment despite Altamira, MX disruptions Continued strong adoption of Opteon Refrigerants with YoY double-digit growth Received permit to expand Teflon PFA resin prod

  4. Slide 4: Second Quarter 2024 Financial Summary

    Second Quarter 2024 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) 2Q24 2Q23 Y-o-Y % ∆ 1Q24 Q-o-Q % ∆ Net Sales $1,538 $1,643 $(105) $1,350 $188 Net Income/ (Loss) 1 $70 $(376) $446 $52 $18 Adj. Net Income 2 $57 $167 $(110) $48 $9 EPS 3 $0.46 $(2.52) $2.98 $0.34

  5. Slide 5: Adjusted EBITDA Bridge

    Adjusted EBITDA Bridge ($ in millions) ($99) $6 ($8) ($2) ($11) ($4) $324 $206 2Q23 Price Volume Costs Other Income Currency Divestitures 2Q24 Price Declines:($99) million due to lower overall market pricing Volume Impacts: $6 million driven by OpteonTM refrigerants product adoption and a slight inc

  6. Slide 6: Segment Summary

    Segment Summary ($ in millions unless otherwise noted) Net Sales TT TSS APM $859 $968 $707 $673 $340 $518 $523 $513 $362 $401 $387 $339 Q2'21 Q2'22 Q2'23 Q2'24 Q2'21 Q2'22 Q2'23 Q2'24 Q2'21 Q2'22 Q2'23 Q2'24 Adjusted EBITDA and Margin (%) TT TSS APM ($ in millions) $217 $216 $213 $214 $161 $87 $80 $

  7. Slide 7: Liquidity Position as of June 30, 2024

    Liquidity Position as of June 30, 2024 ($ in millions unless otherwise noted) Total Liquidity 8 $1.5B Gross debt $4.0B Net Debt 9 $3.4B $1,353 TTM Net Leverage 10 4.4x ($620) $607 Includes $606 million of Restricted restricted cash and cash equivalents for the Water District Settlement Fund $619 ($7

  8. Slide 8: Appendix

    Appendix

  9. Slide 9: Segment Net Sales and Adjusted EBITDA (Unaudited)

    Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) Three Months Ended Three Months Ended June 30, March 31, 2024 2023 2024 SEGMENT NET SALES Titanium Technologies $ 673 $ 707 $ 588 Thermal & Specialized Solutions 513 523 449 Advanced Performance Materials 339 387 299 Other Segment 13

  10. Slide 10: GAAP Net Income (Loss) to Adjusted Net Income and Adjusted EBITDA Reconciliation

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio (Page 1/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Months Ended June 30, March 31

  11. Slide 11: GAAP Net Income (Loss) to Adjusted Net Income and Adjusted EBITDA Reconciliation

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio (Page 1/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Months Ended June 30, March 31

  12. Slide 12: ® 2022 CHEMOURS. ALL RIGHT RESERVED

    ® 2022 CHEMOURS. ALL RIGHT RESERVED

Chemours Company (The) — Q2 2024 Earnings Presentation on 6ix